About Joanna Wolak
Joanna Wolak is CEO and Co-founder, director at Endlyz Therapeutics.
Joanna Wolak first appears on SEC filings in 2021.
Experience
This experience comes from Joanna Wolak's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joanna Wolak in the role, so the role may have started earlier or lasted longer.
Endlyz Therapeutics, Inc. Current
CEO and Co-founder, director
Chief Executive Officer (2021 – Present)
2021 – Present · Boston, MA
Develops potential medicines for people with Parkinson’s disease and other dementias.
TF
The Dementia Discovery Fund
Venture Partner
2020 – 2022
AV
AviadoBio
Board Member
2020 – 2021
EC
Eli Lilly and Company
Neuroinflammation Group Leader
2007 – 2020
UB
University of Bristol
Postdoctoral Research Assistant
2001 – 2004
Key Colleagues at Startups
The people Joanna Wolak works with at each company, as listed on that company's latest Form D.
Endlyz Therapeutics, Inc. · Form D, May 7, 2026
JF
Justian Fox
Director
Donmienne Leung
Director, AbbVie Ventures
Laurence Barker
Partner, SV Health Investors and director
Timothy Edwards
Chairperson, Independent